TRACK 1: LIPOPROTEIN METABOLISM IN VIVO AND IN VITRO |
| CROSS-TALK OF NUCLEAR RECEPTORS IN LIPID METABOLISM AND ATHEROGENESIS |
Chairpersons:
|
F. Kuipers, The Netherlands
V. Olkkonen, Finland |
| |
NUCLEAR RECEPTORS CONTROLLING PLASMA LIPIDS
F. Kuipers, The Netherlands |
| |
NUCLEAR RECEPTORS LINKING CIRCADIAN RHYTHMS TO THE METABOLIC SYNDROME
B. Staels, France |
| REGULATION OF HEPATIC LIPID HOMEOSTASIS AND CROSS-TALK WITH ADIPOSE TISSUE
|
Chairpersons:
|
M. Stoffel, Switzerland
J. Westerbacka, Finland |
| |
REGULATION OF HEPATIC LIPID HOMEOSTASIS AND ETHIOLOGY OF HEPATIC STEATOSIS
M. Stoffel, Switzerland |
| |
FORMATION OF CYTOSOLIC LIPID DROPLETS; RELATION TO INSULIN SENSITIVITY AND VLDL ASSEMBLY
S. Olof-Olofsson, Sweden |
| ROLE OF CHOLESTEROL AND LIPID ORGANIZATION IN DISEASE |
Chairpersons:
|
I. Tabas, USA
E. Ikonen, Finland |
| |
CELLULAR PHYSIOLOGY OF INTRACELLULAR CHOLESTEROL TRAFFICKING AND METABOLISM
E. Ikonen, Finland |
| |
PATHOLOGICAL ISSUES RELATED TO MACROPHAGE CHOLESTEROL TRAFFICKING AND METABOLISM IN ATHEROSCLEROSIS
I. Tabas, USA |
ROLE OF FATTY ACID BINDING PROTEINS AND SCD IN OBESITY AND ATHEROSCLEROSIS
|
Chairpersons:
|
E. Parks, USA
R. Fisher, Sweden |
| |
DYNAMICS AND SOURCERS OF FFAs USED FOR SYNTHESIS OF LIVER FAT AND VLDL
E. Parks, USA |
| |
ADIPOHEPATIC SIGNALING AND THE FATTY LIVER
H. Yki-Jarvinen, Finland |
| |
|
TRACK 2: MOLECULAR GENETICS AND GENE-ENVIRONMENT INTERACTIONS |
NOVEL GENES IN THE REGULATION OF LIPOPROTEIN METABOLISM
|
| Chairpersons: |
A. Soutar, UK
C. Ehnholm, Finland |
| |
GENETICS OF LIPID METABOLISM--FROM GENES TO PUBLIC HEALTH
L. Peltonen, Finland |
| |
DEFECTS IN GENES THAT AFFECT LDL-RECEPTOR FUNCTION
A. Soutar, UK
|
| MOLECULAR GENETICS AND GENE: ENVIRONMENT INTERACTION |
| Chairpersons: |
P. Talmud, UK
A. Kesäniemi, Finland
|
| |
USING GENETICS TO INVESTIGATE WHETHER THE RELATIONSHIP BETWEEN Lp-PLA2 AND CAD RISK IS CAUSAL
P. Talmud, UK |
| |
ATHEROSCLEROSIS: FROM GENETIC POLYMORPHISMS TO SYSTEM GENETICS
L. Tiret, France |
| NOVEL APPROACHES TO STUDY GENE REGULATION IN ATHEROSCLEROSIS AND METABOLIC DISEASES |
Chairpersons:
|
M. Hofker, The Netherlands
M. Savolainen, Finland |
| |
UNRAVELING THE COMPLEX GENETICS OF METABOLIC DISEASE
M. Hofker, The Netherlands |
| |
GENETIC AND GENE-TRANSFER APPROACHES TO STUDY THE PATHOGENESIS AND TREATMENT OF ATHEROSCLEROSIS-RELATED DISEASE
S. Ylä-Herttuala, Finland |
| NOVEL GENETIC APPROACHES TO IDENTIFY NEW GENES |
Chairpersons:
|
J. Sainz, Spain
L. Peltonen-Palotie, Finland |
| |
PROSPECTS AND RESULTS OF GENOME-WIDE LARGE SCALE SNP ASSOCIATION STUDIES
J. Sainz, Spain |
| |
NATURE'S RANDOMISED TRIALS: GENETIC APPROACHES TO EVALUATE THE CAUSAL RELEVANCE OF BIOMARKERS LINKED TO CORONARY DISEASE
A. Hingorani, UK |
| |
|
TRACK 3: CELL BIOLOGY AND METABOLISM OF ARTERIAL WALL |
| INFLAMMATION AND ATHEROSCLEROSIS |
Chairpersons:
|
G.K. Hansson, Sweden
M. Jauhiainen, Finland |
| |
INNATE IMMUNE ACTIVATION IN THE ATHEROSCLEROTIC PLAQUE
G.K. Hansson, Sweden |
| |
ARACHIDONIC ACID METABOLISM AND PLAQUE INSTABILITY
F. Cipollone, Italy |
| PROTEINASES AND PLAQUE REMODELLING IN ATHEROSCLEROSIS |
| Chairpersons: |
A. Newby, UK
M. Tikkanen, Finland |
| |
PROTECTIVE AND HARMFUL EFFECTS OF PROTEINASES ON ATHEROSCLEROTIC PLAQUE STABILITY
A. Newby, UK |
| |
FOCAL MODULATION OF PROTEOLYSIS IN THE ADVANCED ATHEROSCLEROTIC PLAQUE
E. Biessen, The Netherlands
|
| ATHEROSCLEROSIS AND PROGENITOR CELLS |
| Chairpersons: |
S. Dimmeler, Germany
S. Jovinge, Sweden |
| |
ENDOTHELIAL PROGENITOR CELLS AND VASCULAR REPAIR
S. Dimmeler, Germany
|
| |
GENETIC AND EPIGENETIC FACTORS REGULATING ENDOTHELIAL PROGENITOR CELLS
M. Vasa-Nicotera, UK
|
| RETENTION AND MODIFICATION OF ATHEROGENIC LIPOPROTEINS IN ARTERIAL WALL |
| Chairpersons: |
P. Kovanen, Finland
E. Hurt-Camejo, Sweden |
| |
LIPOPROTEIN MODIFICATION – THE KEY FACTOR IN ARTERIAL LIPID ACCUMULATION
P. Kovanen, Finland |
| |
OXIDIZED PHOSPHOLIPIDS AS TRIGGERS OF INFLAMMATION IN ATHEROSCLEROSIS
N. Leitinger, USA
|
| |
|
TRACK 4: RISK FACTORS, DIAGNOSIS AND TREATMENT |
| NUTRITION AND NUTRICEUTICALS IN PREVENTION AND MANAGEMENT OF CVD |
| Chairpersons: |
A.Zampelas, Greece
H. Gylling, Finland |
| |
n-3 FATTY ACIDS IN THE PREVENTION OF CORONARY HEART DISEASE
A. Zampelas, Greece |
| |
NUTRICEUTICALS AND FUNCTIONAL FOODS IN THE MANAGEMENT OF OBESITY AND THE METABOLIC SYNDROME
G. Riccardi, Italy |
| OBESITY AND VISCERAL FAT AS A RISK FACTOR OF CARDIOVASCULAR DISEASES |
| Chairpersons: |
F. Karpe, UK
A. Rissanen, Finland |
| |
FATTY ACID METABOLISM IN ADIPOSE TISSUE IN RELATION TO CARDIOVASCULAR DISEASE
F. Karpe, UK |
| |
ROLE OF CB RECEPTORS IN ADIPOSE TISSUE, LIVER AND ARTERIAL WALL AS CROSSTALK MEDIATORS
F. Mach, Switzerland |
| IMAGING TECHNIQUES IN ATHEROSCLEROSIS DIAGNOSTICS AND PROGRESS MONITORING |
| Chairpersons: |
S. Achenbach, Germany
O. Raitakari, Finland |
| |
CARDIAC COMPUTED TOMOGRAPHY
S. Achenbach, Germany |
| |
MAGNETIC RESONANCE ANGIOGRAPHY AND VESSEL WALL IMAGING; GREAT TOOLS FOR ASSESSING ATHEROSCLEROSIS
J.H.C. Reiber, The Netherlands |
| EPIDEMIOLOGICAL CHANGES OF CORONARY HEART DISEASE RISK IN EUROPE |
| Chairpersons: |
I. Graham , Ireland
J.Viikari , Finland |
| |
CHANGING PANORAMA OF CARDIOVASCULAR DISEASE RISK IN EUROPE: IMPACT ON RISK ASSESSMENT AND MANAGEMENT
I. Graham, Ireland
|
| |
CARDIOVASCULAR DISEASE RISK ASSESSMENT IN EUROPEAN WOMEN: HOW DIFFERENT?
S. Sans, Spain |
